THE CHILDRENS HOSPITAL OF ALABAMA
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $925K
- Transactions
- 682
- Companies
- 40
- Average per transaction
- $1,356
Who reported the payments
| Insulet Corporation | $271,500 |
| Tandem Diabetes Care, Inc. | $133,100 |
| Stryker | $123,604 |
| Nuwellis, Inc. | $87,000 |
| Baxter Healthcare | $34,650 |
| Merck | $28,365 |
| Medtronic | $28,200 |
| Sanofi Pasteur Inc. | $25,000 |
| Sanofi US Services Inc. | $25,000 |
| F. Hoffmann-la Roche AG | $25,000 |
| Abbott | $20,034 |
| AstraZeneca | $15,025 |
| Kyowa Kirin, Inc. | $15,000 |
| Neurocrine Biosciences, Inc. | $15,000 |
| Covidien LP | $12,000 |
| Linvatec Corporation | $10,142 |
| Biofire Diagnostics, LLC | $7,500 |
| Leadiant Biosciences, Inc. | $7,500 |
| Mallinckrodt Hospital Products Inc. | $5,000 |
| Novo Nordisk | $5,000 |
| Olympus America Inc. | $4,382 |
| Siemens Medical Solutions USA, Inc. | $3,009 |
| Apellis Pharmaceuticals, Inc. | $3,000 |
| Pfizer | $2,502 |
| AbbVie | $2,500 |
| Bio-rad Laboratories, Inc. | $2,358 |
| BD | $2,011 |
| Novartis | $1,669 |
| Med-el Corporation | $1,368 |
| Jazz Pharmaceuticals Inc. | $1,095 |
| Mylan Specialty L.p. | $1,000 |
| Advanced Respiratory, Inc | $1,000 |
| Gilead | $1,000 |
| Eli Lilly | $1,000 |
| Chugai Pharmaceutical Co., Ltd. | $781 |
| Cochlear Americas | $492 |
| Masimo Corporation | $487 |
| ECS OPCO 1 LLC | $473 |
| Incyte Corporation | $364 |
| Hollister Incorporated | $307 |